Measles virus vaccine live attenuated
Identification
- Name
- Measles virus vaccine live attenuated
- Accession Number
- DB10315
- Description
Measles virus vaccine live attenuated is a live virus vaccine for simultaneous vaccination against measles, which is a common childhood disease. The vaccine is prepared from the attenuated line of measles virus, derived from Enders' attenuated Edmonston strain and propagated in chick embryo cell culture.
- Type
- Biotech
- Groups
- Approved, Investigational
- Biologic Classification
- Vaccines
Attenuated - Synonyms
- Live attenuated measles virus (Schwartz strain)
- Measles vaccine (live)
- Measles virus live antigen
- Measles virus live antigen, A
- Measles virus strain enders' attenuated edmonston live (attenuated) antigen
- Measles virus strain enders' attenuated edmonston live antigen
- Measles virus vaccine live
- Measles virus vaccine live attenuated
- Measles Virus Vaccine Live, Enders' attenuated Edmonston strain
- Measles virus vaccine, inactivated
- Measles virus vaccine, live
- Measles virus vaccine, live, attenuated
- Measles virus vaccine,live attenuated
Pharmacology
- Indication
- Not Available
- Associated Conditions
- Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More- Pharmacodynamics
- Not Available
- Mechanism of action
- Not Available
- Absorption
- Not Available
- Volume of distribution
- Not Available
- Protein binding
- Not Available
- Metabolism
- Not Available
- Route of elimination
- Not Available
- Half-life
- Not Available
- Clearance
- Not Available
- Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More- Toxicity
- Not Available
- Affected organisms
- Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Unlock Additional DataAbatacept The therapeutic efficacy of Measles virus vaccine live attenuated can be decreased when used in combination with Abatacept. Adalimumab The therapeutic efficacy of Measles virus vaccine live attenuated can be decreased when used in combination with Adalimumab. Aldesleukin The therapeutic efficacy of Measles virus vaccine live attenuated can be decreased when used in combination with Aldesleukin. Alefacept The therapeutic efficacy of Measles virus vaccine live attenuated can be decreased when used in combination with Alefacept. Alemtuzumab The therapeutic efficacy of Measles virus vaccine live attenuated can be decreased when used in combination with Alemtuzumab. Altretamine The therapeutic efficacy of Measles virus vaccine live attenuated can be decreased when used in combination with Altretamine. Amsacrine The therapeutic efficacy of Measles virus vaccine live attenuated can be decreased when used in combination with Amsacrine. Anakinra The therapeutic efficacy of Measles virus vaccine live attenuated can be decreased when used in combination with Anakinra. Antilymphocyte immunoglobulin (horse) The therapeutic efficacy of Measles virus vaccine live attenuated can be decreased when used in combination with Antilymphocyte immunoglobulin (horse). Antithymocyte immunoglobulin (rabbit) The therapeutic efficacy of Measles virus vaccine live attenuated can be decreased when used in combination with Antithymocyte immunoglobulin (rabbit). Additional Data Available- Extended DescriptionExtended DescriptionAvailable for Purchase
Extended description of the mechanism of action and particular properties of each drug interaction.
Learn more - SeveritySeverityAvailable for Purchase
A severity rating for each drug interaction, from minor to major.
Learn more - Evidence LevelEvidence LevelAvailable for Purchase
A rating for the strength of the evidence supporting each drug interaction.
Learn more - ActionActionAvailable for Purchase
An effect category for each drug interaction. Know how this interaction affects the subject drug.
Learn more
- Food Interactions
- Not Available
Products
- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Unlock Additional DataMeasles Virus Vacc Live Att Freez Dried Inj Powder, for solution Subcutaneous Iaf Biovac Inc. 1991-12-31 1997-08-20 Canada Measles Virus Vaccine Live Atten Dried Powder, for solution Subcutaneous Connaught Laboratories Ltd. 1982-12-31 2000-07-18 Canada Additional Data Available- Application NumberApplication NumberAvailable for Purchase
A unique ID assigned by the FDA when a product is submitted for approval by the labeller.
Learn more - Product CodeProduct CodeAvailable for Purchase
A governmentally-recognized ID which uniquely identifies the product within its regulatory market.
Learn more
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image M-M-R II Measles virus vaccine live attenuated (1000 [TCID_50]/0.5mL) + Mumps virus strain B level jeryl lynn live antigen (12500 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL) Injection, powder, lyophilized, for suspension Subcutaneous A-S Medication Solutions 1971-04-21 Not applicable US M-M-R II Measles virus vaccine live attenuated (1000 [TCID_50]/0.5mL) + Mumps virus strain B level jeryl lynn live antigen (12500 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL) Injection, powder, lyophilized, for suspension Subcutaneous Physicians Total Care, Inc. 1996-08-07 2012-06-30 US M-M-R II Measles virus vaccine live attenuated (1000 [TCID_50]/0.5mL) + Mumps virus strain B level jeryl lynn live antigen (12500 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL) Injection, powder, lyophilized, for suspension Subcutaneous Merck Sharp & Dohme Corp. 1971-04-21 Not applicable US M-M-R II Measles virus vaccine live attenuated (1000 TCID50/0.5mL) + Mumps virus strain B level jeryl lynn live antigen (12500 TCID50/0.5mL) + Rubella virus vaccine (1000 TCID50/0.5mL) Powder, for solution Subcutaneous Merck Ltd. 1979-12-31 Not applicable Canada Measles Virus Vaccine, Live, Attenuated (dried) Measles virus vaccine live attenuated (1000 unit) + Water (0.6 ml) Kit; Liquid; Powder, for solution Subcutaneous Connaught Laboratories Ltd. 1996-12-11 2000-08-02 Canada Priorix Measles virus vaccine live attenuated (103.0 CCID50/0.5mL) + Mumps virus strain B level jeryl lynn live antigen (103.7 CCID50/0.5mL) + Rubella virus vaccine (103.0 CCID50/0.5mL) Kit; Powder, for solution Intramuscular; Subcutaneous Glaxosmithkline Inc 1998-12-04 Not applicable Canada ProQuad Measles virus vaccine live attenuated (1000 [TCID_50]/0.5mL) + Mumps virus strain B level jeryl lynn live antigen (20000 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL) + Varicella Zoster Vaccine (Live/attenuated) (9772 [PFU]/0.5mL) Injection, powder, lyophilized, for suspension Subcutaneous Merck Sharp & Dohme Corp. 2015-07-01 Not applicable US ProQuad Measles virus vaccine live attenuated (1000 [TCID_50]/0.5mL) + Mumps virus strain B level jeryl lynn live antigen (20000 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL) + Varicella Zoster Vaccine (Live/attenuated) (9772 [PFU]/0.5mL) Injection, powder, lyophilized, for suspension Subcutaneous Merck Sharp & Dohme Limited 2005-09-06 2018-08-31 US ProQuad Measles virus vaccine live attenuated (3 log10 tcid50/0.5mL) + Mumps virus strain B level jeryl lynn live antigen (4.3 log10 tcid50/0.5mL) + Rubella virus vaccine (3 log10 tcid50/0.5mL) + Varicella Zoster Vaccine (Live/attenuated) (3.99 log10 tcid50/0.5mL) Powder, for solution Subcutaneous Merck Ltd. 2014-05-09 Not applicable Canada
Categories
- Drug Categories
- Classification
- Not classified
Chemical Identifiers
- UNII
- MFZ8I7277D
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
- AHFS Codes
- 80:12.00 — Vaccines
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Prevention BCG Infection / Immune Response / Reaction - Vaccine 1 4 Completed Prevention Chickenpox / Hepatitis A / Mumps / Rubella / Rubeola 1 4 Completed Prevention Encephalitis, Japanese B / Mumps / Rubella / Rubeola 1 4 Completed Prevention Hepatitis A Virus 1 4 Completed Prevention Mumps / Rubella / Rubeola 2 3 Completed Prevention Acellular Pertussis / Diphtheria / Poliomyelitis / Tetanus 1 3 Completed Prevention Acellular Pertussis / Diphtheria / Tetanus 1 3 Completed Prevention Bacterial Infections / Neisseria Meningitidis / Virus Diseases 2 3 Completed Prevention Bacterial Infections / Virus Diseases 1 3 Completed Prevention Chickenpox Vaccines / Varicella 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, powder, lyophilized, for solution Subcutaneous 1000 [CCID_50]/0.5mL Injection, powder, lyophilized, for suspension Subcutaneous Injection, powder, for suspension Intramuscular; Subcutaneous 1000 CCID50/0.5mL Injection, powder, lyophilized, for solution Subcutaneous 0.5 ml Powder, for solution Subcutaneous Kit; liquid; powder, for solution Subcutaneous Injection, powder, lyophilized, for solution Intramuscular; Subcutaneous 1000 TCID Injection, powder, lyophilized, for suspension Subcutaneous 1000 [TCID_50]/0.5mL Injection, powder, for solution Intramuscular; Subcutaneous 103 CCID50/0.5mL Injection, powder, for solution Subcutaneous 103 CCID50/0.5mL Kit; powder, for solution Intramuscular; Subcutaneous Injection, solution Intramuscular; Subcutaneous 1000 CCID Injection, powder, for solution Intramuscular; Subcutaneous 1000 CCID Injection, powder, lyophilized, for solution Intramuscular; Subcutaneous 10 CCID Injection, solution Intramuscular; Subcutaneous 5011 CCID50/0.5mL Injection, powder, for solution Intramuscular; Subcutaneous 5011 CCID50/0.5mL Injection, powder, for solution Subcutaneous 10 CCID Injection, powder, lyophilized, for suspension Subcutaneous 1000 CCID_50 Injection, powder, lyophilized, for solution Subcutaneous 10 CCID Injection, powder, for suspension Intramuscular; Subcutaneous 1000 [TCID_50]/0.5mL Injection, powder, lyophilized, for suspension Intramuscular; Subcutaneous 1000 [TCID_50]/0.5mL Powder, for solution Subcutaneous Injection, powder, lyophilized, for suspension Intramuscular; Subcutaneous 3 log10/0.5ml Injection, powder, lyophilized, for suspension Subcutaneous 1000 CCID50/5ml Injection, powder, lyophilized, for suspension Subcutaneous 1000 CCID_50/0.5ml Injection Subcutaneous 1000 CCID50/0.5mL Injection, powder, for solution 1000 CCID_50 - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created on December 01, 2015 13:03 / Updated on January 23, 2021 21:03